Health Care: Drugs

Galena Biopharma Inc (GALE: NASDAQ)

$1.36 n/a | n/a%
05/22/15 - 04:00 PM ET
Company Income Statement
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Sales 9.32M 2.49M 0.00 0.00
Cost of Sales 954.00K 199.00K 0.00 0.00
Gross Operating Profit 8.36M 2.29M 0.00 0.00
Selling, General, and Administrative Expenses 31.34M 14.60M 6.58M 9.25M
Research & Development 28.35M 21.08M 14.61M 11.54M
Operating Income before D & A (EBITDA) -51.33M -33.39M -21.20M -20.79M
Depreciation & Amortization 889.00K 452.00K 49.00K 163.00K
Interest Income 0.00 0.00 0.00 30.00K
Other Income - Net 16.73M -40.98M -13.14M 9.27M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -35.50M -74.82M -34.39M -11.65M
Interest Expense 1.11M 807.00K 33.00K 0.00
Pre-Tax Income -36.61M -75.63M -34.43M -11.65M
Income Taxes 0.00 1.05M -1.05M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -36.61M -76.68M -33.32M -11.48M
Net Income From Discontinued Operations 0.00 0.00 -1.64M 0.00
Net Income From Total Operations -36.61M -76.68M -34.97M -11.48M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -36.61M -76.68M -34.97M -11.48M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-36.61M -76.68M -33.32M -11.48M
Preferred Dividends
Net Income Available To Common -36.61M -76.68M -33.32M -11.48M
Basic EPS from Continuing Ops. -0.31 -0.85 -0.53 -0.32
Basic EPS from Discontinued Ops. 0.00 0.00 -0.03 0.00
Basic EPS from Total Operations -0.31 -0.85 -0.56 -0.32
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -0.31 -0.85 -0.56 -0.32
Basic Normalized Net Income/Share -0.31 -0.85 -0.53 -0.32
EPS fr Continuing Ops. -0.31 -0.85 -0.53 -0.32
EPS fr Discontinued Ops 0.00 0.00 -0.03 0.00
EPS fr Total Ops. -0.31 -0.85 -0.56 -0.32
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -0.31 -0.85 -0.56 -0.32
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-0.31 -0.85 -0.53 -0.32
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with GALE

Latest GALE Headlines from TheStreet

More Financial News for GALE

Press Releases for GALE

See All Press Releases

Partner Headlines for GALE

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter